TBPH
Theravance Biopharma Inc
Price:  
9.44 
USD
Volume:  
243,048.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH WACC - Weighted Average Cost of Capital

The WACC of Theravance Biopharma Inc (TBPH) is 6.7%.

The Cost of Equity of Theravance Biopharma Inc (TBPH) is 8.45%.
The Cost of Debt of Theravance Biopharma Inc (TBPH) is 5.00%.

Range Selected
Cost of equity 7.10% - 9.80% 8.45%
Tax rate 1.30% - 2.40% 1.85%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.0% - 7.4% 6.7%
WACC

TBPH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.80%
Tax rate 1.30% 2.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.0% 7.4%
Selected WACC 6.7%